CYCLOSPORIN A
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Medical College of Wisconsinprotein_peptidePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Precursor B-Cell Lymphoblastic Leukemia-Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Monomethyl Fumarate Medical College of Wisconsin | Phase 2 | B |
cc-5013 Institut de Cancérologie de la Loire | Phase 2 | B |
Same molecule, other indications
CYCLOSPORIN A is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →